You have 0 items in your cart
Introduction
Epithalon is a synthetic tetrapeptide that has attracted scientific interest for decades within the fields of peptide chemistry, molecular biology and longevity research. Although many researchers recognise the compound by name, fewer understand where it originated or the scientific work that led to its development.
Understanding who discovered Epithalon provides valuable historical context for peptide science and helps explain how advances in molecular biology have contributed to the design of synthetic research peptides.
This article is intended for educational purposes and discusses the scientific history of a research peptide.
Who Developed Epithalon?
Epithalon was developed by researchers led by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia.
Professor Khavinson and his colleagues spent many years investigating naturally occurring peptide regulators and exploring how short synthetic peptides could be designed to study biological regulation and cellular processes.
Their work established Epithalon as one of the best-known synthetic tetrapeptides in peptide research.
The Scientific Background
The development of Epithalon followed decades of research into naturally occurring peptide molecules involved in cellular regulation.
Scientists were interested in understanding whether very short peptide sequences could provide insight into complex biological signalling systems.
This work encouraged researchers to investigate synthetic peptide analogues that could be studied under controlled laboratory conditions.
How Was Epithalon Developed?
Epithalon was designed as a synthetic analogue based on earlier investigations into naturally occurring peptide regulators.
Its development involved extensive research into:
- Peptide chemistry
- Molecular biology
- Amino acid sequencing
- Protein interactions
- Analytical testing
- Structural stability
Researchers carefully evaluated how small structural changes influenced peptide characteristics and laboratory performance.
Why Was Epithalon Developed?
Scientists developed Epithalon to improve understanding of peptide regulation and cellular biology.
Research involving the peptide has contributed to investigations into:
- Molecular signalling
- Cellular regulation
- Peptide engineering
- Protein chemistry
- Structure–activity relationships
- Analytical science
Its development also demonstrated how synthetic tetrapeptides can be used to investigate complex biological systems.
Why Is Epithalon Important in Scientific Research?
Epithalon remains an important subject of laboratory investigation because it contributes to broader understanding of peptide biology and molecular regulation.
Researchers continue to investigate topics including:
- Peptide stability
- Cellular signalling
- Molecular interactions
- Protein regulation
- Analytical chemistry
- Synthetic peptide design
As peptide science continues to evolve, Epithalon remains an established research compound within molecular biology.
Ongoing Scientific Interest
Current research continues to explore:
- Peptide chemistry
- Cell biology
- Molecular signalling pathways
- Structure–activity relationships
- Laboratory analytical techniques
- Synthetic peptide optimisation
Each new investigation contributes to expanding scientific knowledge surrounding short regulatory peptides.
Frequently Asked Questions
Who developed Epithalon?
Epithalon was developed by Professor Vladimir Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology.
Is Epithalon naturally occurring?
No. Epithalon is a synthetic tetrapeptide developed through peptide engineering based on earlier research into naturally occurring peptide regulators.
Why was Epithalon created?
Researchers developed Epithalon to investigate peptide regulation, molecular biology and cellular signalling.
Why is Epithalon still studied?
Scientists continue to investigate Epithalon to improve understanding of peptide chemistry, molecular interactions and biological regulation.
Conclusion
The development of Epithalon represents an important milestone in synthetic peptide research. Through the work of Professor Vladimir Khavinson and his colleagues, scientists expanded understanding of short regulatory peptides and their role in molecular biology.
Understanding who developed Epithalon provides valuable historical context for researchers interested in peptide chemistry, synthetic peptide engineering and the continuing evolution of longevity-related research.
This article is provided for educational and scientific purposes only. It discusses the scientific history of a research peptide and is not intended as medical advice or guidance on clinical use.